pharma · Hypoactive Sexual Desire Disorder
anwerina Deutschland
Warner Chilcott Deutschland GmbH
Warner Chilcott Deutschland is a pharma organization headquartered in EU. Primary therapeutic focus areas include Hypoactive Sexual Desire Disorder. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 pa
mannheim, DE HQ
10 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- mannheim, DE
- Employees
- 10
- Programs
- 1
- Drugs
- 1
- Patents
- 0
Testosterone Transdermal System
Phase 3 · small molecule · Hypoactive Sexual Desire Disorder
Testosterone Transdermal System for Hypoactive Sexual Desire Disorder is a Phase 3 program (small_molecule) at Warner Chilcott Deutschland GmbH with 1 ClinicalTrials.gov record(s).
Internal code 2001134 and Yr 2-4 OL
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Warner Chilcott Deutschland GmbH
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Hypoactive Sexual Desire Disorder
- Status
- completed
- Trials
- 1